These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 31061017)

  • 1. Effect of liraglutide on body weight and pain in patients with overweight and knee osteoarthritis: protocol for a randomised, double-blind, placebo-controlled, parallel-group, single-centre trial.
    Gudbergsen H; Henriksen M; Wæhrens EE; Overgaard A; Bliddal H; Christensen R; Boesen MP; Knop FKK; Astrup A; Rasmussen MU; Bartholdy C; Daugaard C; Bartels EM; Ellegaard K; Heitmann BL; Kristensen LE
    BMJ Open; 2019 May; 9(5):e024065. PubMed ID: 31061017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of the glucagon-like peptide-1 receptor agonist liraglutide added to insulin therapy in poorly regulated patients with type 1 diabetes--a protocol for a randomised, double-blind, placebo-controlled study: the Lira-1 study.
    Dejgaard TF; Knop FK; Tarnow L; Frandsen CS; Hansen TS; Almdal T; Holst JJ; Madsbad S; Andersen HU
    BMJ Open; 2015 Apr; 5(4):e007791. PubMed ID: 25838513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protocol for a randomised controlled trial of the combined effects of the GLP-1 receptor agonist liraglutide and exercise on maintenance of weight loss and health after a very low-calorie diet.
    Jensen SBK; Lundgren JR; Janus C; Juhl CR; Olsen LM; Rosenkilde M; Holst JJ; Stallknecht BM; Madsbad S; Torekov SS
    BMJ Open; 2019 Nov; 9(11):e031431. PubMed ID: 31678947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protocol for a randomised, double-blinded, placebo-controlled, double-dummy 6-week clinical trial comparing the treatment effects of the glucagon-like peptide 1 receptor agonist liraglutide versus the bile acid sequestrant colesevelam on bile acid malabsorption.
    Kårhus ML; Brønden A; Lyng Forman J; Haaber A; Vilsbøll T; Sonne DP; Knop FKK
    BMJ Open; 2021 Feb; 11(2):e044711. PubMed ID: 33558360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liraglutide after diet-induced weight loss for pain and weight control in knee osteoarthritis: a randomized controlled trial.
    Gudbergsen H; Overgaard A; Henriksen M; Wæhrens EE; Bliddal H; Christensen R; Nielsen SM; Boesen M; Knop FK; Astrup A; Rasmussen MU; Bartholdy C; Daugaard CL; Ellegaard K; Heitmann BL; Bartels EM; Danneskiold-Samsøe B; Kristensen LE
    Am J Clin Nutr; 2021 Feb; 113(2):314-323. PubMed ID: 33471039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sperm count is increased by diet-induced weight loss and maintained by exercise or GLP-1 analogue treatment: a randomized controlled trial.
    Andersen E; Juhl CR; Kjøller ET; Lundgren JR; Janus C; Dehestani Y; Saupstad M; Ingerslev LR; Duun OM; Jensen SBK; Holst JJ; Stallknecht BM; Madsbad S; Torekov SS; Barrès R
    Hum Reprod; 2022 Jun; 37(7):1414-1422. PubMed ID: 35580859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liraglutide and the management of overweight and obesity in people with schizophrenia, schizoaffective disorder and first-episode psychosis: protocol for a pilot trial.
    Whicher CA; Price HC; Phiri P; Rathod S; Barnard-Kelly K; Reidy C; Thorne K; Asher C; Peveler R; McCarthy J; Holt RIG
    Trials; 2019 Nov; 20(1):633. PubMed ID: 31747930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin for knee osteoarthritis with obesity: study protocol for a randomised, double-blind, placebo-controlled trial.
    Lim YZ; Wang Y; Urquhart DM; Estee MM; Wluka AE; Heritier S; Cicuttini FM
    BMJ Open; 2023 Dec; 13(12):e079489. PubMed ID: 38070903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial.
    le Roux CW; Astrup A; Fujioka K; Greenway F; Lau DCW; Van Gaal L; Ortiz RV; Wilding JPH; Skjøth TV; Manning LS; Pi-Sunyer X;
    Lancet; 2017 Apr; 389(10077):1399-1409. PubMed ID: 28237263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of liraglutide in patients with type 2 diabetes and end-stage renal disease: protocol for an investigator-initiated prospective, randomised, placebo-controlled, double-blinded, parallel intervention study.
    Idorn T; Knop FK; Jørgensen M; Jensen T; Resuli M; Hansen PM; Christensen KB; Holst JJ; Hornum M; Feldt-Rasmussen B
    BMJ Open; 2013; 3(4):. PubMed ID: 23624993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism evaluation of a lifestyle intervention for patients with musculoskeletal pain who are overweight or obese: protocol for a causal mediation analysis.
    Lee H; Wiggers J; Kamper SJ; Williams A; O'Brien KM; Hodder RK; Wolfenden L; Yoong SL; Campbell E; Haskins R; Robson EK; McAuley JH; Williams CM
    BMJ Open; 2017 Jul; 7(6):e014652. PubMed ID: 28674135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of a telehealth physiotherapist-delivered intensive dietary weight loss program combined with exercise in people with knee osteoarthritis and overweight or obesity: study protocol for the POWER randomized controlled trial.
    Bennell KL; Jones SE; Hinman RS; McManus F; Lamb KE; Quicke JG; Sumithran P; Prendergast J; George ES; Holden MA; Foster NE; Allison K
    BMC Musculoskelet Disord; 2022 Jul; 23(1):733. PubMed ID: 35907828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protocol for Meal-time Administration of Exenatide for Glycaemic Control in Type 1 Diabetes Cases (The MAG1C trial): a randomised, double-blinded, placebo-controlled trial.
    Johansen NJ; Dejgaard TF; Lund A; Vilsbøll T; Andersen HU; Knop FK
    BMJ Open; 2018 Jun; 8(6):e021861. PubMed ID: 29950475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moxibustion versus diclofenac sodium gel for the treatment of knee osteoarthritis: a study protocol for a double-blinded, double-placebo, randomised controlled trial.
    Zhou JY; Luo L; Zhu LL; Yin HY; Wu Q; Peng JX; Zhang CS; Lv P; Tang Y; Yu SG
    BMJ Open; 2017 Apr; 7(4):e012879. PubMed ID: 28404609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can metformin relieve tibiofemoral cartilage volume loss and knee symptoms in overweight knee osteoarthritis patients? Study protocol for a randomized, double-blind, and placebo-controlled trial.
    Ruan G; Yuan S; Lou A; Mo Y; Qu Y; Guo D; Guan S; Zhang Y; Lan X; Luo J; Mei Y; Zhang H; Wu W; Dai L; Yu Q; Cai X; Ding C
    BMC Musculoskelet Disord; 2022 May; 23(1):486. PubMed ID: 35598008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protocol for a single-centre, parallel-arm, randomised controlled superiority trial evaluating the effects of transcatheter arterial embolisation of abnormal knee neovasculature on pain, function and quality of life in people with knee osteoarthritis.
    Landers S; Hely A; Harrison B; Maister N; Hely R; Lane SE; Gill SD; Page RS
    BMJ Open; 2017 May; 7(5):e014266. PubMed ID: 28554913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomised controlled trial of referral to a telephone-based weight management and healthy lifestyle programme for patients with knee osteoarthritis who are overweight or obese: a study protocol.
    O'Brien KM; Wiggers J; Williams A; Campbell E; Wolfenden L; Yoong S; Robson EK; McAuley J; Haskins R; Kamper SJ; Williams C
    BMJ Open; 2016 Mar; 6(3):e010203. PubMed ID: 26940110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of 12-week garlic supplementation on symptom relief in overweight or obese women with knee osteoarthritis.
    Salimzadeh A; Alipoor E; Dehghani S; Yaseri M; Hosseini M; Feinle-Bisset C; Hosseinzadeh-Attar MJ
    Int J Clin Pract; 2018 Jun; 72(6):e13208. PubMed ID: 29790635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pain reduction with oral methotrexate in knee osteoarthritis, a pragmatic phase iii trial of treatment effectiveness (PROMOTE): study protocol for a randomized controlled trial.
    Kingsbury SR; Tharmanathan P; Arden NK; Batley M; Birrell F; Cocks K; Doherty M; Edwards CJ; Garrood T; Grainger AJ; Green M; Hewitt C; Hughes R; Moots R; O'Neill TW; Roddy E; Scott DL; Watt FE; Torgerson DJ; Conaghan PG
    Trials; 2015 Mar; 16():77. PubMed ID: 25872649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Tanezumab on Joint Pain, Physical Function, and Patient Global Assessment of Osteoarthritis Among Patients With Osteoarthritis of the Hip or Knee: A Randomized Clinical Trial.
    Schnitzer TJ; Easton R; Pang S; Levinson DJ; Pixton G; Viktrup L; Davignon I; Brown MT; West CR; Verburg KM
    JAMA; 2019 Jul; 322(1):37-48. PubMed ID: 31265100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.